Hypera S.A. (HYPMY)
OTCMKTS · Delayed Price · Currency is USD
4.220
-0.180 (-4.09%)
Aug 7, 2025, 3:58 PM EDT
Despegar.com Market Cap
Hypera has a market cap or net worth of $2.80 billion as of August 8, 2025. Its market cap has decreased by -15.28% in one year.
Market Cap
2.80B
Enterprise Value
4.20B
Revenue
1.22B
Ranking
n/a
PE Ratio
20.52
Stock Price
$4.22
Market Cap Chart
Since April 18, 2008, Hypera's market cap has increased from 1.59B to 2.80B, an increase of 76.14%. That is a compound annual growth rate of 3.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 2.80B | 52.29% |
| Dec 30, 2024 | 1.84B | -60.72% |
| Dec 28, 2023 | 4.67B | -14.36% |
| Dec 29, 2022 | 5.46B | 70.31% |
| Dec 30, 2021 | 3.20B | -23.62% |
| Dec 30, 2020 | 4.20B | -25.09% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.57M |
| Glass House Brands | 474.59M |
| Spruce Biosciences | 427.59M |
| Northwest Biotherapeutics | 368.08M |
| CytoDyn | 337.23M |